Index Inclusion and Stock Reaction
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) shares increased by 3.5% on Monday following the company's addition to both the Russell 3000 and Russell 2000 indexes. The inclusion took effect after the U.S. market close on Friday as part of the 2026 Russell indexes reconstitution, which ranks the 4,000 U.S. stocks by market‑capitalization as of April 30 and updates membership semi‑annually. Membership in the Russell 3000 automatically confers inclusion in the small‑cap Russell 2000 as well as the relevant growth and value style sub‑indexes, and will remain until the next semi‑annual reconstitution.
Significance of Russell Indexes
Russell indexes are widely used by investment managers and institutional investors for passive index funds and as benchmarks for active strategies, with approximately $12.2 trillion of assets benchmarked against Russell’s U.S. indexes. Consequently, the addition of Orchestra BioMed may raise the company’s visibility and weight in a large pool of institutional capital.
Company Profile
Orchestra BioMed is a biomedical firm developing medical‑device technologies through partnerships with global device manufacturers. The company currently has two flagship product candidates that are undergoing pivotal clinical trials.
Index Methodology
FTSE Russell determines index membership primarily through objective market‑capitalization rankings and style attributes, without discretionary selection.